(via Thenewswire.ca)

December 23, 2014 / TNW-ACCESSWIRE / Vancouver, British Columbia / Vodis Pharmaceuticals Inc. (the "Company" or "Vodis") (CSE: VP / FSE: 1JV) is pleased to announce the arrival of a brand new Tier 8 upgraded vault to further ensure Health Canada's approval at the time of inspection. The vault will be the final component to be installed and the company has provided Health Canada notice of its readiness for a final inspection.

Otto Folprecht, CEO & Director states: "I am excited that the Company has finally received the Vault, as this is the last item to be installed prior to final inspection. Over the next several days the Company and its contractors will install the safe. We have notified Health Canada that we are ready for a final inspection, and are waiting for a date from the Government of Canada. We have spent the past year preparing our systems and building out our 12,000 square facility in order to pass Health Canada's world-leading, rigorous requirements."

Since Vodis received its Ready-To-Build Permit in January of 2014, the company has worked diligently to upgrade its production facility to Health Canada's standards

ABOUT VODIS PHARMACEUTICALS

Vodis is one of Canada's foremost brand names in the medical marijuana business. Its master grow teams have consistently won or placed at each competition they have entered. The company is awaiting a Health Canada inspection to begin production at its state-of-the-art 12,000 square foot facility in Canada, which will have a theoretical capacity of up to 200 pounds per month or up to $8.7 million in annual revenue.

For further information please contact:

Brian Gusko

CFO & Director

Vodis Pharmaceuticals

104-1037 West Broadway

Vancouver, BC V6H 1E3

direct: 1-866-210-1420 ext. 106

web: www.vodis.ca

Forward-Looking Information:

This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business and trading in the common stock of Newnote Financial Corp. The forward-looking information is based on certain key expectations and assumptions made by the company's management. Although the company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the company can give no assurance that they will prove to be correct. These forward-looking statements are made as of the date of this press release and the company disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

The CSE has not reviewed, approved or disapproved the content of this press release.

Copyright (c) 2014 TheNewswire - All rights reserved.